Rating History for Pacira Pharmaceuticals (PCRX) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for PCRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/17/2025 Douglas Tsao New Coverage Buy
(N/A)		 38.00
(N/A)		 23.78
(22.00)		 -7.49% Details